Tretinoin EP Impurity D
|
維A酸EP雜質(zhì)D
|
005300-03-8
|
Phenylbutyryl chloride
|
苯丁酰氯
|
18496-54-3
|
Piperonyl chloride
|
胡椒基氯
|
20850-43-5
|
(S)-2-(3-fluorobenzylamide)propionamide
|
(S)-2-(3-氟芐胺基)丙酰胺
|
1132879-89-0
|
(S)-2-(4-(3-chlorobenzyloxy)benzylamido)propionic acid
|
(S)-2-(4-(3-氯芐氧基)芐胺基)丙酸
|
1160513-60-9
|
Fluocinolone EP Impurity A
|
氟輕松EP雜質(zhì)A
|
106931-78-6
|
Diisopropyl hydrazine dicarboxylate
|
肼二甲酸二異丙酯
|
19740-72-8
|
R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
|
(3R)-3-[4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶基]-1-叔丁氧羰基碳酸酯
|
1022150-11-3
|
(S)-(5-broMo-2-chlorophenyl)(4- (tetrahydrofuran-3-yloxy)phenyl) Methanone
|
(5-溴-2-氯苯基)[4-[[(3S)-四氫-3-呋喃基]氧基]苯基]甲酮
|
915095-84-0
|
Methotrexate Impurity SM2-4 (2-Phenyl-1,3-Dioxane-5-one)
|
甲氨蝶呤雜質(zhì)SM2-4(2-苯基-1,3-二惡烷-5-酮)
|
52941-82-9
|
2-Nitroaniline
|
2-硝基苯胺
|
88-74-4
|
Cilnidipine Impurity 3
|
西尼地平雜質(zhì)3
|
99522-79-9
|
Sildenafil dieth
|
西地那非二醚
|
1346602-67-2
|
Cefuroxime axetil Impurity A
|
頭孢呋辛酯雜質(zhì)A
|
123458-61-7
|
N-(4-Pyridyl)-2-Hydroxybutyramide
|
N-(4-吡啶基)-2-羥基丁酸
|
1864897-67-5
|
Fluvoxamine maleate impurity III. Dimaleate
|
馬來酸氟伏沙明雜質(zhì)Ⅲ 二馬來酸鹽
|
|
|
馬來酸氟伏沙明雜質(zhì)Ⅱ
|
|
Cefazolin sodium USP Impurity E
|
頭孢唑林鈉USP雜質(zhì)E
|
478494-71-2
|
2-(4-phenoxybenzoyl)malononitrile
|
330792-68-2
|
1-(2,4-dinitrophenyl)pyridinium chloride
|
氯化-1-(2.4-二硝基苯基)吡啶翁鹽
|
4185-69-7
|
Nimodipine Impurity B
|
尼莫地平雜質(zhì)B
|
21881-78-7
|
N-Methylcaprolactam
|
N-甲基己內(nèi)酰胺對照品
|
2556-73-2
|
N-Nitroso Metoprolol
|
N-亞硝基美托洛爾
|
138768-62-4
|
3-Pyrrolidinol
|
3-羥基吡咯烷
|
40499-83-0
|
α-Hydroxy Olopatadine
|
α-羥基奧洛他定鹽酸鹽
|
1331668-21-3
|
N-Deshydroxyethyl Dasatinib
|
N-脫羥基乙基達(dá)沙替尼
|
910297-51-7
|
Compound T24622
|
化合物 T24622
|
1467059-66-0
|
AZD-9574
|
|
2756333-39-6
|
Naltrexone
|
納曲酮
|
16590-41-3
|
|
N-脫BOC 多西他賽
|
133524-69-3
|
|
惡唑烷卡巴他賽
|
1373171-12-0
|
|
多西他賽雜質(zhì)19
|
183133-97-3
|
Tigecycline Impurity 3
|
替加環(huán)素雜質(zhì)3
|
|
Azilsartan INT1-A
|
阿齊沙坦INT1-A
|
|
Flurbiprofen Impurity 12
|
氟比洛芬雜質(zhì)12
|
|
Metoprolol Impurity D
|
琥珀酸美托洛爾雜質(zhì)D
|
1486464-40-7
|
Budesonide Impurity B
|
布地奈德雜質(zhì)B
|
1040085-98-0
|
Budesonide Impurity G
|
布地奈德雜質(zhì)G
|
137174-25-5
|
Sitagliptin N-Boc Impurity
|
N-Boc取代西格列汀
|
486460-23-5
|
Azilsartan SM3
|
阿齊沙坦SM3
|
0078-09-1
|
Azilsartan SM1-B
|
阿齊沙坦SM1-B
|
21606-04-2
|
Azilsartan SM1-E
|
阿齊沙坦SM1-E
|
57113-91-4
|
Salbutamol ImpurityE
|
沙丁胺醇雜質(zhì)E
|
754926-25-5
|
Difelikefalin Acetate
|
醋酸地非法林
|
1024829-44-4
|
N-(1-(10H-phenothiazin-10-yl)propan-2-yl)-N-methylnitrous amide
|
N-(1-(10H-吩噻嗪-10-基)丙-2-基)-N-甲基亞氮酰胺
|
94511-44-1
|
Nimodipine Impurity IV
|
尼莫地平雜質(zhì)IV
|
|
Cefotaxime Impurity D
|
頭孢噻肟EP雜質(zhì)D
|
63527-53-7
|
Azilsartan DNT5 intermediate state
|
阿齊沙坦DNT5中間態(tài)
|
147404-82-8
|
FLP-Impurity A
|
FLP-雜質(zhì)A
|
1354055-68-7
|
N-nitroso-N-methyl-4-aminobutyric acid
|
N-亞硝基-N-甲基-4-氨基丁酸(NMBA)
|
61445-55-4
|
1,3-Bis(2,6-diisopropylphenyl)-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate
|
1,3-雙(2,6-二異丙苯基)-4,5-二氫咪唑 四氟硼酸鹽
|
282109-83-5
|
Cefaclor Impurity 39
|
頭孢克洛雜質(zhì)39
|
|
Tryptophan impurity C
|
色氨酸雜質(zhì)C
|
13441-51-5
|
Azilsartan SM5-B
|
阿齊沙坦SM5-B
|
24973-49-7
|
Linezolid Impurity B
|
利奈唑胺雜質(zhì)B對照品
|
496031-57-3
|
Rasagiline impurity 8 hydrochloride
|
雷沙吉蘭雜質(zhì)8鹽酸鹽
|
10409-00-4
|
EP Impurity C
|
EP雜質(zhì)C
|
620-12-2
|
Azilsartan INT4-E
|
阿齊沙坦INT4-E
|
1397836-41-7
|
Diclofenac sodium impurity III
|
雙氯芬酸鈉雜質(zhì)III
|
146607-19-4
|
Salmeterol EP Impurity G
|
沙美特羅EP雜質(zhì)G
|
2470130-36-8
|
Metoprolol Impurity C
|
琥珀酸美托洛爾雜質(zhì)C
|
1956321-87-1
|
Labetalol hydrochloride impurity INT1-3
|
鹽酸拉貝洛爾雜質(zhì)INT1-3
|
|
4-Chloro-6-propoxy-2-(propylthio)pyrimidin-5-amine
|
4-氯-6-丙氧基-2-(丙基硫代)嘧啶-5-胺
|
|
Upadacitinib P3-12
|
烏帕替尼P3-12
|
|
LS-M3-Impurity C
|
LS-M3-雜質(zhì)C
|
|
Perindopril tert-butylamine impurity 2
|
培哚普利叔丁胺雜質(zhì)2
|
|
Cefixime dimer 3
|
|
|
Cefixime dimer 2
|
Cefixime dimer 2
|
|
FSM/Impurity H
|
FSM/雜質(zhì)H
|
|
De-boc Cabazitaxel
|
|
1638286-64-2
|
6-fluoro-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine
|
6-氟-3-(1H-吡咯并[2,3-c]吡啶-1-基)異喹啉-5-胺
|
1841078-87-2
|
(R)-GAMMA-VALEROLACTONE
|
(R)-二氫-5-甲基-2(3H)-呋喃酮
|
58917-25-2
|
M1-Impurity A [2-(2,4-dichloro-5-fluorobenzoyl)-3-(ethylamino)acrylate
|
M1-雜質(zhì)A【2-(2,4-二氯-5-氟苯甲?;?3-(乙氨基)丙烯酸酯】
|
104600-28-4
|
Tretinoin EP Impurity G
|
維A酸EP雜質(zhì)G
|
13100-69-1
|
Nimodipine Impurity F
|
尼莫地平雜質(zhì)F
|
39562-18-0
|
(2E,4E)-5-(aniline)penta-2,4-dienal
|
(2E,4E)-5-(苯胺基)戊-2,4-二烯醛
|
17432-66-5
|
Methyl lipoate
|
硫辛酸甲酯
|
46236-19-5
|
2-(3-ethoxyphenoxy)bromoethane
|
2-(3-乙氧基苯氧基)溴乙烷
|
26690-39-1
|
1-Ethyl-3-(4-phenoxyphenyl)-1H-pyrazole[3,4-d]pyrimidin-4-amine
|
1-乙基-3-(4-苯氧基苯基)-1H-吡唑[3,4-d]嘧啶-4-胺
|
2213398-76-4
|
Fluvoxamine Impurity Ⅳ
|
馬來酸氟伏沙明雜質(zhì)Ⅳ
|
89035-92-7
|
Fluvoxamine Impurity I
|
馬來酸氟伏沙明雜質(zhì)I
|
259526-43-7
|
Diethyl 2-(6-bromohexyl)malonate
|
2-(6-溴己基) 丙二酸二乙酯
|
6557-85-3
|
Emedastine Impurity INT3-G
|
依美斯汀雜質(zhì)INT3-G
|
40019-65-6
|
Fluocinolone EP Impurity E
|
氟輕松EP雜質(zhì)E
|
68352-03-4
|
1,3-Dimethylamino-2-propanol
|
1,3-二甲氨基-2-丙醇
|
83804-96-0
|
4-(3-(4-guanidinobenzoyl)guanidinyl)benzoic acid
|
2491698-53-2
|
LGLT-ZZ-70
|
|
397246-12-7
|
Azilsartan Impurity SM01-8
|
阿齊沙坦雜質(zhì)SM01-8
|
177965-03-6
|
(S)-2-(4-(3-fluorobenzyloxy)benzylamido)propanol
|
(S)-2-(4-(3-氟芐氧基)芐胺基)丙醇
|
1376616-14-6
|
2,3-Dihydroxypropyl 4-phenylbutyrate
|
2,3-二羥丙基 4-苯基丁酸酯
|
1292210-87-7
|
2,6-DI-TERT-BUTYL-4-THIOCYANATO-PHENOL
|
2,6-二叔丁基-4-硫氰基苯酚
|
3957-71-9
|
(E)-Cocoa acid
|
(E)-可可酸
|
62163-45-5
|
(S)-2-((4-((3-fluorobenzyl)oxy)benzylidene)amino)propanamide
|
(S)-2-[(4-((3-氟芐基)氧基)亞芐基)氨基]丙酰胺
|
1000370-31-9
|
3-[(3-Fluorobenzyl)oxy]benzaldehyde
|
3-(3-氟芐氧基)苯甲醛
|
590353-54-1
|
(Z)-Cocoa acid
|
(Z)-可可酸
|
62163-44-4
|
Erythromycin C
|
紅霉素C標(biāo)準(zhǔn)品
|
1675-02-1
|
8-((3R,4S)-1-benzyl-4- ethylpyrrolidin-3-yl)-3H -imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
|
8-((3R,4S)-1-芐基-4-乙基吡咯烷-3-基)-3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪
|
|
Salbutamol EP Impurity B
|
硫酸沙丁胺醇雜質(zhì)B
|
96948-64-0
|
Ceftazidime EP Impurity C
|
頭孢他啶EP雜質(zhì)C
|
3432-88-0
|
Lactic anhydride
|
乳酸酐
|
97-73-4
|